Top Stock Recommendations: Choice Broking Recommends Buy on Rubicon Research, M&M, and Torrent Pharma
_609329560.jpg)
Amid ongoing volatility in the Indian stock market, technical analysts continue to spot selective buying opportunities backed by strong chart setups, high trading volumes, and favourable momentum indicators.
Choice Equity Broking has issued Buy recommendations on three prominent stocks showing distinct bullish momentum: Rubicon Research, Mahindra & Mahindra (M&M), and Torrent Pharmaceuticals.
Overview of Top Stock Recommendations
| Name July | ||||
|---|---|---|---|---|
| Rubicon Research | ₹1,530.60 (+4.38%) | ₹1,675 | ₹1,450 | Rising channel pattern & strong OBV accumulation |
| M&M | ₹3,230.00 (+1.72%) | ₹3,400 | ₹3,120 | Range breakout above ₹3,220 with bullish moving average crossover |
| Torrent Pharma | ₹5,049.90 (+0.33%) | ₹5,425 | ₹4,900 | Higher highs & higher lows structure near swing highs |
Detailed Technical Analysis
1. Rubicon Research
Market Price: ₹1,530.60
Target Price: ₹1,675 | Stop-Loss: ₹1,450
Rubicon Research continues to trade in a well-defined rising channel on the daily time frame, reflecting sustained buying interest on minor dips. The stock maintains its position above major moving averages, with the 20-day Exponential Moving Average (EMA) acting as a reliable dynamic support. The upward trajectory of the On-Balance Volume (OBV) indicator confirms steady institutional accumulation.
2. Mahindra & Mahindra (M&M)
Market Price: ₹3,230.00
Target Price: ₹3,400 | Stop-Loss: ₹3,120
M&M has confirmed a range breakout by closing above its critical resistance barrier at ₹3,220, backed by a noticeable surge in trading volume. Technically, the 20-day Moving Average has crossed above the 50-day Moving Average, signalling accelerating short-term momentum. With the Relative Strength Index (RSI) standing at 58.79, the stock remains well below the overbought threshold, leaving ample headroom for further upside.
3. Torrent Pharmaceuticals
Market Price: ₹5,049.90
Target Price: ₹5,425 | Stop-Loss: ₹4,900
Torrent Pharma maintains an established primary uptrend characterised by a continuous series of higher highs and higher lows. Following a minor pullback, the stock has rebounded sharply toward its recent swing high. The RSI currently reads 67.43, indicating strong momentum without entering extreme overbought territory. A decisive close above the ₹5,086 resistance level is expected to trigger fresh buying toward the ₹5,425 mark.
Disclaimer: Stock market investments are subject to market risks. The technical views, target prices, and stop-loss levels provided above are based on recommendations issued by Choice Equity Broking and should not be construed as direct financial advice. Investors should consult qualified financial advisors before making investment decisions.
